Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.62M Hold
6,446
1.23% 20
2026
Q1
$1.4M Sell
6,446
-120
-2% -$26.6K 1.12% 25
2025
Q4
$1.5M Hold
6,566
1.16% 22
2025
Q3
$1.52M Sell
6,566
-50
-0.8% -$10.2K 1.16% 22
2025
Q2
$1.23M Hold
6,616
0.97% 27
2025
Q1
$1.39M Hold
6,616
1.2% 22
2024
Q4
$1.18M Buy
+6,616
New +$1.22M 1.02% 26

Other funds holding ABBV

Finward Bancorp's ABBV Position: Q2 2026 in Review

Finward Bancorp held its AbbVie (ABBV) position steady in Q2 2026 at 6,446 shares worth $1.62M. The position accounts for 1.23% of the portfolio, ranked #20.

Finward Bancorp first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Finward Bancorp held 6,446 shares of AbbVie worth $1.62M as of Q2 2026.
  • Finward Bancorp left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 1.23% of Finward Bancorp's portfolio in Q2 2026, its #20 holding.
  • Finward Bancorp first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Finward Bancorp's 13F filing for Q2 2026, filed 16 Jul 2026.